''Immunic, Inc. Announces U.S. Food and Drug Administration Allowance of its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19''

#stocks #stockstowatch #COVID__19 #biotech #USA 

https://t.co/z1Bk9aXVOj